MedPath

Effect of Acupoint Application on IVF Outcome and Follicular Fluid Metabolism in Patients With Phlegm-Dampness Polycystic Ovary Syndrome

Phase 1
Recruiting
Conditions
Polycystic ovary syndrome
Registration Number
ITMCTR1900002715
Lead Sponsor
Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
Female
Target Recruitment
Not specified
Inclusion Criteria

(1) Aged 18-39 years;
(2) It conforms to the diagnostic criteria of western medicine for polycystic ovary syndrome;
(3) It meets the diagnostic criteria of phlegm-dampness polycystic ovary syndrome;
(4) 24 BMI or less 27.9 or less;
(5) Informed consent, volunteer subjects.

Exclusion Criteria

(1) Complicated with endometriosis, uterine fibroids, endometrial polyps and other gynecological diseases, as well as serious diseases of cardiovascular and cerebrovascular, liver, kidney and hematopoietic system, mental illness, abnormal thyroid and adrenal function.
(2) Those who have received hormone drug therapy within half a year.
(3) Allergic to dressing.
(4) There are open wounds in the applied part.
(5) Those who do not meet the inclusion criteria, are not applied according to the regulations, and cannot judge the efficacy or incomplete data affect the efficacy and safety judgment.

Study & Design

Study Type
Interventional study
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the rate of oocyte-obtained;rate of pregnancy;Optimal rate of embryo;Follicular fluid metabolites;
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath